These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 658610)
21. Prandial insulin requirements in insulin-dependent diabetics: effects of size, time of day, and sequence of meals. Service FJ; Rizza RA; Hall LD; Westland RE; O'Brien PC; Clemens AH; Haymond MW; Gerich JE J Clin Endocrinol Metab; 1983 Nov; 57(5):931-6. PubMed ID: 6352728 [TBL] [Abstract][Full Text] [Related]
22. Perfect normalization of excessive glucagon responses to intravenous arginine in human diabetes mellitus with the artificial beta-cell. Kawamori R; Shichiri M; Kikuchi M; Yamasaki Y; Abe H Diabetes; 1980 Sep; 29(9):762-5. PubMed ID: 7002690 [TBL] [Abstract][Full Text] [Related]
24. Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics. Baron AD; Schaeffer L; Shragg P; Kolterman OG Diabetes; 1987 Mar; 36(3):274-83. PubMed ID: 2879757 [TBL] [Abstract][Full Text] [Related]
25. On the role of the gut in diabetic hyperglucagonaemia. Lund A Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385175 [TBL] [Abstract][Full Text] [Related]
26. Glucose counterregulation in patients after pancreatectomy. Comparison with other clinical forms of diabetes. Polonsky KS; Herold KC; Gilden JL; Bergenstal RM; Fang VS; Moossa AR; Jaspan JB Diabetes; 1984 Nov; 33(11):1112-9. PubMed ID: 6389228 [TBL] [Abstract][Full Text] [Related]
27. Islet hormonal regulation of glucose turnover during exercise in type 1 diabetes. Shilo S; Sotsky M; Shamoon H J Clin Endocrinol Metab; 1990 Jan; 70(1):162-72. PubMed ID: 1967178 [TBL] [Abstract][Full Text] [Related]
28. Effect of overnight restoration of euglycemia on glucose effectiveness in type 2 diabetes mellitus. Basu R; Basu A; Nielsen M; Shah P; Rizza RA J Clin Endocrinol Metab; 1999 Jul; 84(7):2314-9. PubMed ID: 10404795 [TBL] [Abstract][Full Text] [Related]
29. Influence of hyperglycemia on insulin's in vivo effects in type II diabetes. Revers RR; Fink R; Griffin J; Olefsky JM; Kolterman OG J Clin Invest; 1984 Mar; 73(3):664-72. PubMed ID: 6368585 [TBL] [Abstract][Full Text] [Related]
30. Effects of somatostatin added to insulin in a glucose-controlled insulin infusion system. Selam JL; Chenon D; Pham TC; Gagnol JP; Sany C; Thomas N; Gravagne G; Orsetti A; Mirouze J Diabetologia; 1981 Aug; 21(2):126-30. PubMed ID: 6114891 [TBL] [Abstract][Full Text] [Related]
31. Glucagon response to arginine after treatment of diabetes mellitus. Ohneda A; Ishii S; Horigome K; Yamagata S Diabetes; 1975 Sep; 24(9):811-9. PubMed ID: 1158041 [TBL] [Abstract][Full Text] [Related]
32. Abnormalities of endogenous glucagon and insulin in unstable diabetes. Reynolds C; Molnar GD; Horwitz DL; Rubenstein AH; Taylor WF; Jiang NS Diabetes; 1977 Jan; 26(1):36-45. PubMed ID: 830563 [TBL] [Abstract][Full Text] [Related]
33. Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors. Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P Diabetes; 1982 Jul; 31(7):641-7. PubMed ID: 6298039 [TBL] [Abstract][Full Text] [Related]
34. Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion. Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P; Gerich JE Diabetes; 1983 Feb; 32(2):134-41. PubMed ID: 6337896 [TBL] [Abstract][Full Text] [Related]
35. Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus. Gutniak M; Orskov C; Holst JJ; Ahrén B; Efendic S N Engl J Med; 1992 May; 326(20):1316-22. PubMed ID: 1348845 [TBL] [Abstract][Full Text] [Related]
36. Greater efficacy of pulsatile insulin in type I diabetics critically depends on plasma glucagon levels. Paolisso G; Sgambato S; Passariello N; Scheen A; D'Onofrio F; Lefèbvre PJ Diabetes; 1987 May; 36(5):566-70. PubMed ID: 2883055 [TBL] [Abstract][Full Text] [Related]
37. Lack of glucagon response in glucose counter-regulation in type 1 (insulin-dependent) diabetics: absence of recovery after prolonged optimal insulin therapy. Bolli G; Calabrese G; De Feo P; Compagnucci P; Zega G; Angeletti G; Cartechini MG; Santeusanio F; Brunetti P Diabetologia; 1982 Feb; 22(2):100-5. PubMed ID: 7037510 [TBL] [Abstract][Full Text] [Related]
38. Dynamic study of the blood viscosity of insulin-dependent diabetics by means of an artificial pancreas. Drouin P; Rousselle D; Pointel JP; Voisin G; Stoltz JF; Clemens AH; Debry G Horm Metab Res Suppl; 1979; (8):107-10. PubMed ID: 395064 [TBL] [Abstract][Full Text] [Related]
39. Transient hepatic response to glucagon in man: role of insulin and hyperglycemia. Ferrannini E; DeFronzo RA; Sherwin RS Am J Physiol; 1982 Feb; 242(2):E73-81. PubMed ID: 7039338 [TBL] [Abstract][Full Text] [Related]
40. Conjoint regulation of glucagon concentrations via plasma insulin and glucose in dairy cows. Zarrin M; Wellnitz O; Bruckmaier RM Domest Anim Endocrinol; 2015 Apr; 51():74-7. PubMed ID: 25577602 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]